Plain-English translation of NCT07239479 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Neoplasms research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether dexmedetomidine—a sedative medication that reduces pain and promotes calm without affecting breathing—can work alongside standard anesthesia gas to reduce how much anesthetic you need during laparoscopic colon surgery. Half of the participants will receive dexmedetomidine plus the standard anesthetic gas, while the other half will receive standard anesthetic gas alone. The goal is to see if this medication helps you need less anesthetic, recover faster, and have fewer side effects after surgery.
Current anesthesia practices for colon surgery work well but can sometimes lead to slower recovery and side effects like nausea. This trial exists to explore whether the medication could reduce the amount of anesthetic needed while helping patients wake up faster and feel better after surgery.
You likely qualify if…
You likely don't qualify if…
You will come to Tam Anh General Hospital in Vietnam for your planned laparoscopic colon surgery. Before surgery, you will be randomly assigned to receive either the new medication (dexmedetomidine) combined with standard anesthetic gas, or standard anesthetic gas alone. During surgery, your heart rate, blood pressure, oxygen levels, and pain control will be monitored carefully. After surgery, the research team will track how quickly you wake up, how much pain you feel, and whether you experience nausea—comparing your recovery to the group that did not receive the new medication.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
Vietnam